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Abstract Due to the economic crisis and the 
predominance of drug expenditure in healthcare costs, 
the cooperation of groups of hospitals to negotiate with 
suppliers and centralize warehouses has been a recent 
trend in the pharmaceutical supply chain.  
This paper shows the economic convenience of 
centralizing the hospitals’ inventory decisions (how 
much/when to order) based on the sharing of medical 
prescriptions of patients along the supply chain.  
The logistic network under investigation (TO BE model) 
integrates: a central pharmacy negotiating with suppliers, 
collecting hospital orders, storing and distributing 
materials; a number of hospitals feeding their medical 
units with materials; and a number of medical units 
taking care of their patients. 
The study is carried out comparing the cost performances 
of the proposed model with a non-cooperative one(in 
which hospitals manage their stocks individually) by 
means of simulation.  
 
Keywords Pharmaceutical SCM – Drug Inventory 
Management – GPO – Electronic Medical Records – 






Drug expenditure accounts for more than a sixth of the 
health spending in OECD countries, second only to 
inpatient and outpatient care costs [1]. 
 
Furthermore, due to the economic crisis, countries and 
organizations are adopting demand-side and supply-
side management measures to cope with the issue [2]. 
The first actions arefocused on prescribers and patients, 
mainly through introducing prescription guidelines, 
administrationmonitoring and patient co-payment; the 
supply-side measures include, for example, negotiation 
with suppliers, reference pricing, expenditure ceilings 
and pooled procurements, also by means of groups of 
purchasing organizations (GPOs).  
 
Looking at the hospital supply chain, the huge impact of 
the logistic costs on the hospital’s operating budget 
(around 35% according to [3]) has led many researchers 
to improve inventory control policies [4] and several 
structures belonging to the same geographical areahave 
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With regard to the drugs’ information flow, many 
technological advances have been introduced (for example, 
collection of electronic prescriptions in the field of 
electronic medical records – EMR - or drug and medical 
device tracking for reduction of the risk of wrong 
administration [5]). Despite this,Vila-Parrish and Simmons 
[6] state that data provided by these innovations are often 
not exploited to obtain supply chain cost savings.  
 
This paper aims at covering the gap found in the 
literature, proposing a new approach to hospital 
materials management (HMM), in which purchasing 
negotiation and inventory management are carried out 
integrating the supply chain by means of real-time 
patient information sharing.  
 
The paper is organized as follows: in section 2, the 
literature review is analysed; section 3 deals with the 
description of the investigated logistic models; in section 
4, the notation is reported; section 5 shows the cost 
function used as a performance measure for the logistic 
configurations; section 6 describes the case study; section 
7 presents the design and analysis of experiments. The 
conclusions are drawn in section 8. 
 
2. Literature review 
 
New trends towards healthcare supply chain integration 
can be classified in three logistic strategies [7]: 
- GPOs; 
- partial/total centralization of medical supplies; 
- outsourcing to a 3PL. 
 
In the following, the three approaches and the level of 





The advantages and disadvantages of GPO have been 
described [8]: the main advantages are price-quantity 
discount and other purchasing-related costs (transaction 
and administrative costs), focus on core activities and, in 
the public sector, prevention of corruption; the principal 
disadvantage is indicated as the coordination cost.  
 
Rego et al. [8] proposed a method to find the least 
expensive GPO (in terms of number, size and 
composition of the group) for a set of hospitals willing to 
cooperate, starting from the assumption that there is no 
direct relationship between a larger size of GPO and 
lower prices.  
 
As an example, the introduction of GPO allowed a saving 
of about 8% of the total purchasing cost in New Zealand 
[2]. 
2.2Partial/total centralization of medical supplies 
 
Centralization of storage has been a topic of interest of 
logisticssince distribution networks began to be diffused, 
as a way to minimize the holding and penalty costs of 
inventory and shared supply chain risks [9]. 
 
Humbel and Tshudi in [7] reported the example of a 
group of Swiss hospitals that centralized purchasing and 
reception of merchandise, obtaining a saving of 5% of the 
cost of logistic activities. 
 
Studies by Eppen [10] and, later, by Chen and Lin [11] 
demonstrated the statistical economies of scale achievable 
by means of inventory centralization. In particular, they 
showed the economic convenience in the case of normally 
distributed demand (the first author), or concave 
inventory cost functions (the second authors), adding that 
the saving depends on the correlation of demands. In the 
case of demands identically distributed and uncorrelated, 
Eppen [10] provedthat the total cost of the decentralized 
system is proportional to the number of warehouses 
while, in the centralized system, it is proportional to its 
square root. 
 
Obviously, another research question in the centralization 
of inventories is the distribution policy, because it implies 
intensification of transportations. 
 
In a multi-echelon inventory system, Baboli et al. [12] 
analysed the replenishment problem from a central 
warehouse to hospital pharmacies, incorporating the 
transportation cost in the inventory optimization 
problem. A distinction was made between decentralized 
and centralized replenishments: in the first case, 
companies tend to minimize their own costs, while in 
the second, the partners try to find a global optimum for 
the whole system. In conditions of constant demand rate 
and lead time and hindered shortage, the authors 
proposed a method to identify the best quantity and 
period of replenishment, taking into account 
warehousing costs and penalty costs for orders consigned 
in advance, in order to exploit the capacity of vehicles 
used for transportations. 
 
Essoussi and Ladet [7]suggested a cooperative scheme for 
centralization of medical supplies, where the purchasing 
group was provided by a common logistical platform that 
performs the cross-docking of materials and a number of 
local depots, each one allocated to a cluster of hospitals. 
Then, in the case of a singleitem/single vendor problem, 
they developed a heuristic procedure to find the number 
and location of depots, the allocation of hospitals to each 
depot and the inventory policy to adopt in order to 
reduce shortages and outdating.  
 
Int J Eng Bus Manag, 2014, 6:21 | doi: 10.5772/589392 www.intechopen.com
2.3 Outsourcing to a 3PL 
 
The main reason to outsource healthcare inventory 
management is the expected increase in the service level 
that the new operator, thanks to its expertise, can 
provide to the system, together with the complete 
freeing of hospitals’ facilities and staff from non-clinical 
activities, while many evaluation criteria can be used to 
choose the best supplier [13]. Nicholson et al. [14] 
investigated the savings obtainable in a single review 
period model of non-critical items (the minimum service 
level has to be 90 %) with zero lead times (including 
transportation times). The cost savings ranged from 2-
3% of the total holding and penalty costs, and the higher 
echelon was able to provide a higher service level. 
 
Another literature contribution to outsourcing is the 
“extended VMI” presented by Danese [15]. The vendor 
managed inventory (VMI) is an inventory management 
strategy in which suppliers decide the inventory level 
and the orders’ quantities and timing on the basis of 
information communicated by customers, sometimes 
also retaining the financial responsibility of buyers [16]. 
Danese [15] reporteda case study of the adoption of the 
VMI in the upstream/downstream pharmaceutical 
supply network, from raw materials’ suppliers to drugs’ 
distribution centres. The downstream members shared 
data about sales forecast and inventory levels. A central 
function elaborated the distribution requirement 
planning (DRP), which was shared with manufacturers 
in order to elaborate their material requirement 
planning (MRP) and generate production and 
purchasing plans. According to the VMI approach, 
finally, manufacturers and suppliers could confirm or 
modify the orders proposed by the DRP-MRP system. 
The author concludedby stating that future researches 
should address an extension of this model to a 
collaborative planning, forecasting and replenishment 
(CPFR) problem. 
 
2.4 Information sharing in the pharmaceutical supply chain 
 
The presented logistic strategies imply information 
sharing about inventory levels among supply chain 
actors, but no inventory management study examines this 
aspect in depth along the supply chain. 
 
Two groups of information are considered in literature 
[17]: downstream information (demand forecasts) and 
upstream information (supplier capacity and lead time). 
 
In the field of downstream information sharing, Dobson 
et al. [18] proposed a data-driven waste reduction 
project in a hospital pharmacy, using the pharmacy 
information system to collect cancellation of orders from 
the medical unit in realtime, avoiding the preparation, 
at the hospital pharmacy level, of useless compounded 
sterile products (for intravenous drips) delivered daily. 
The authors estimated the savings in terms of 
employees’ time and number of wasted doses. They 
evaluated the possibility of rescheduling the 
preparation of daily batches in order to minimize the 
impact of cancellations, to schedule multiple production 
batches or prepare the less expensive compounds first, 
according to the cancellation probability distribution 
function during a day.  
 
In the case of upstream information sharing, Mehrabi et 
al.[19] assessed the economic impact of lead time 
information sharing on safety stocks in a two-echelon 
pharmaceutical supply chain (central pharmacy and 
hospital pharmacy), quantifying the reduction of 
uncertainty in terms of reduction in the total cost of the 
inventory system. 
 
2.5 Research gap and study aims 
 
Apart from the logistic strategies of the supply chain, the 
data provided by the technological advances introduced 
in healthcare inventory management (from computer 
physician order entry systems to radio-frequency 
identification tags – RFID - for traceability of materials 
[20]) have never been exploited in a whole supply chain 
from patient to suppliers, to obtain cost savings [6].  
 
This kind of supply chain integration – achievable by 
means of real-time data sharing about requirement 
forecasts (based on patient information) and inventory 
positions – is considered the open research challenge for 
hospital inventory management [6].  
 
This study aims at investigating the performance 
improvements achievable by means of the sharing of 
patients’ requirements data collected in the hospital’s 
electronic medical records (EMR) along the supply chain.  
 
Because only by integrating the internal supply chain can 
the benefits of integration with the external one be 
enjoyed[21], we investigated in a previous paper [22] the 
convenience of adopting the new system in a hospital 
with three medical units. 
 
In this study, instead, we assessthe performance of a 
wider supply chain network of three echelons. A number 
of medical units and hospital pharmacies are considered, 
and a central pharmacy is added, in charge of pooling 
requirements, receiving incoming materials from 
suppliers, cross-docking and distributing them in the 
nearby hospitals. The possibility of obtaining price-
quantity discounts is evaluated. A significant cluster of 
drugs and the stochastic behaviour of their demand is 
taken into account by means of simulation. 
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3. Description of models 
 
This section describes the proposed model (TO BE logistic 
system) as compared to a non-cooperative one (AS IS). 
See Figure 1 for a graphical representation. 
 
 
Figure 1. Representation of AS IS and TO BE logistic systems 
 
3.1 AS IS logistic system 
 
The AS IS logistic system is constituted by a number of 
hospitals that manage their stocks individually. Two 
echelonscan be identified [23, 24]:  
- hospital pharmacies (one for each hospital), in 
charge of negotiating prices with suppliers (for a 
medium period of time), ordering from suppliers, 
performing the quality control and handling of the 
incoming materials, holding and distributing 
materials to medical units after having evaluated the 
medical units’ requests in clinical and financial 
terms. This echelon manages medical unit urgencies 
(when a drug is not available for administrations) 
inside the hospital, accessing the medical unit 
information system (which is not always updated) 
and activating urgent transport procedures; 
- medical units, where patients are hospitalized. The 
medical unit’s nurse manager delivers drug orders to 
the hospital pharmacy. Nurses place incoming 
materials in a local warehouse or closet and administer 
them to patients according to medical prescriptions. 
 
The inventory management policy adopted at both 
echelons to release orders is the common periodic review 
par level servicing approach, whereby orders are placed 
each review period (RP) as the difference between a 
predetermined maximum quantity to keep in stock at 
each warehouse (par level, S) and the available inventory 
on hand (AV) [14]. 
 
3.2 TO BE logistic system 
 
The TO BE logistic system is an integrated supply chain 
of three echelons where at the medical unit level, for 
clinical and traceability reasons, medical prescriptions 
and drug administrations to patients are recorded in the 
EMR. The prescriptions and the inventory levels(derived 
by delivery and consumption information) are shared in 
real time along the supply chain, and used to decide 
order quantities at each echelon (a detailed description of 
the information records and the hospital information 
system is reported in [5]). 
 
The logistic activities at each echelon are the following: 
- central pharmacy echelon: 
o negotiation of prices with suppliers, relying on 
bigger purchasing quantities than a single 
hospital (configured as a GPO); 
o periodic aggregation of orders coming from 
hospitals by means of a shared information 
platform; 
o transmission of orders to the selected supplier, 
which can refer to a single actor for any problem; 
o inventory centralization (which ensures that 
penalty and holding costs are minimized 
according to [10-11]). This level receives the 
incoming materials, controls their quality 
(avoiding the repetition of activity at each 
hospital pharmacy) and temporarily stores them; 
o materials distribution. This level is equipped 
with means of transport to serve the hospitals 
(which have a single contact point) by delivering 
the requested materials. This feature allows 
suppliers to avoid replenishing each single 
hospital pharmacy, and is another reason for 
GPO bargaining power;  
o urgency management. In case of urgency, 
knowing the inventory level at each warehouse, 
the downstream supply chain can be considered 
as a virtual warehouse, and the request can be 
managed with urgent transport procedures; 
 
- hospital pharmacy echelon. Receipt and distribution 
of materials to medical units; 
- medical unit echelon. Storage of incoming materials 
and administration to patients. 
 
The collaborative purchasing and replenishment model is 
grounded ina requirements-based inventory management 
policy, the MRP method, with a fixed order period (FOP) 
lot sizing approach (for technical issues, see [25-26]).  
 
Prescriptions are evaluated each review period (RP) and, 
if a requirement for a medical unit exists, order quantities 
to be provided by the hospital pharmacy are computed 
by aggregating the needs of a specific period of time 
(FOP). Finally, the replenishment is planned at the latest 
time, according to the hospital pharmacy’s lead time. The 
same applies for the hospital pharmacy’s orders from the 
central pharmacy, and when the central pharmacy 
requires materials from distributors. 
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4. Notation 
 
Both models’ behaviours are analysed for a period of 
time	� � ���� � � ��� � � ���, where the time base unit is the 
time bucket (��) (according to the MRP slang [27]). 
 
The following notation is defined for a geographical area: 
- �: central pharmacy; 
- ℎ:hospital pharmacy, with ℎ � � being the set of 
hospital pharmacies; 
- �: medical unit, with � � � being the set of medical 
units belonging to hospitals; 
- �: distributor, with � � � being the set of 
distributors of drugs.  
 
There are four echelons considered (���� �� �). The 
logistic costs are evaluated for the first three, while the 
fourth is the system’s feeder (it provides the materials to 
the supply chain).  
 
The materials that flow throughout the supply chain are 
drugs, characterized by:  
- �:drug code (pharmaceutical), with � � �; 
- ��: stock decay rate, expressing the deterioration of 
drugs during the time; 
- ���: time between two physician rounds to 
prescribe drugs in the medical unit m.  
 
The cost parameters of the echelons (i) are: 
- ���: disposal cost per unit of package (for reverse 
logistics); 
- ℎ��: holding cost rate, for financial and insurance 
costs; 
- ���: handling costs per unit of package; 
- ���: physical system cost (housing cost), related to 
the physical storage of a package (including the cost 
for energy, space, amortization, security, etc.). 
 
The cost parameters of the interaction between echelons 
(i,k) are: 
- �����: ordering cost at echelon i to order a drug code 
from k (independently of quantities); 
- ������: cost of urgent stockout repair at echelon i 
thanks to the availability at echelon k(independentof 
quantity); 
- �����: cost of transportation from k to i. 
 
The inventory decisions’ variables and data are: 
- ��������: quantity of drug available; 
- ������: fixedorder period. This is the lot sizing 
policy chosen in the application of the MRP; 
- �����: replenishment lead time that passes from the 
order request by echelon i to k till the consignment 
by echelon kto i; 
- �����������:	stockout quantity at i to be released from k; 
- �����: reviewperiod. This is the period between two 
consecutive controls of the inventory level; 
- ����������: quantity ordered by I from k; 
- ���������� : quantity consigned by k to i; 
- �����: transportation time that passes from the 
departure of a delivery from echelon k till the 
consignment to i; 
- ����: service factor. Multiplied by the standard 
deviation of the demand for an item, it allows 
determination of the safety stock for the item, which 
is the quantity to keep in stock at warehouses to 
manage the variability in drug demand during the 




Having defined the two logistic systems, the research 
question to answer is how far the TO BE model is 
economical in comparison with the AS IS one, taking into 
account tangible and intangible aspects. 
 
The HMM costs are: 
- ���������: handling cost, associated with the handling 
of drug packages in the warehouse to prepare an 
order delivery 
 
��������� � 	��� � ����������     (1) 
 
- ���������: ordering cost, cost related to the issue of an 
order from i to k 
 
���������� � ����� � ���� � ����    (2) 
 
· ���� � ����: Dirac delta, taking into account the 
presence of an order during the time bucket 
 
���� � ���� � �
�		��	���������� > 0	
0		����	          (3) 
 
- �������: purchasing cost, subjected to quantity 
discount. It is attributed to the last echelon 
interacting with the distributors, and it is a 
continuous linear function of the order size  
 
�������� � ���������� � �� � �� � ��)           (4) 
 
· ��:unit price for a drug package. 
· ��: percentage of discount per unit of drug 
package. 
 
- �������� : warehousing cost, characterized by three 
components [28]: physical system cost (or housing 
cost), holding cost (proportional to the interest rate) 
and wasting cost (which occurs when items are no 
longer fit for use)  
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�������� = �������� � ���� � �� � �� � �� � ���� � ����    (5) 
 
- ��������: transportation cost, independent of the 
quantity transported from k to i 
 
�������� = 	 ����� � ���� ����  (6) 
 
· ���� ����: Dirac delta taking into account the 
transportation cost only if at least one drug 
replenishment is planned  
 
���� ���� = �
�		��		���	���������� > 0	
	0		����																		            (7) 
 
- ����������� : stockout cost, independent of the stockout 
quantity at the echelon i 
 
����������� = ������� � ����������� � �� � ������������� �	 
 






0			����																							          (9) 
 
������������ = �
�			��	����������� > 0	���	� = �
0			����																							 	 					(10)	
 
The HMM total cost (C) in the observation time T, which 
can be evaluated in both the TO BE (���	��) and the AS IS 
logistic configurations (���	��) is thus: 
 
� = 	∑ ∑ �∑ ���������� � ���� � 	�������� � ��� � �������� �� ���� 	�����
∑ ����������� � ���� � ����������� � ����� � ���������� �� ���� ���� �          (11) 
 
 
 Point of consumption 
Variable Model m h c d
���� 
AS IS 0 1 0 0 
TO BE 0 1 1 0 
��� 
AS IS 0 1 0 0 
TO BE 0 0 1 0 
���  
AS IS 1 1 0 0 
TO BE 1 1 1 0 
 
Table 1. Values of the binary variables ��� at the points of 
consumption 
 
 Couple of adjacent points 
of consumption 
Variable Model m, h h, c h, d c, d 
���� and�����  
AS IS 1 0 1 0 
TO BE 1 1 0 1 
����  
AS IS 1 0 0 0 
TO BE 1 1 0 0 
 
Table 2. Values of the binary variables ����  for each connection 
between points of consumption 
The binary variables ��� and ����  used in the cost formula 
have the values reported in Table 1 and 2, depending on 
the logistic system and the connections of the supply 
chain network. 
 
6. Case study 
 
With the objective of carrying out the comparison of the 
performances of the two configurations (AS IS and TO 
BE), we collected, for a one-year period, the drug 
demand, time and cost data from a group of medium-
sized acute hospitals belonging to the same Italian region, 
accounting for a fifth of the regional drug expense.  
 
Quantitative data from hospital information systems, 
time and method studies, technical evaluations, budgets 
and profit and loss accounts were analysed, together with 
qualitative information coming from semi-structured 
interviews.  
 
Finally, the following supply chainhas been analysed: 
- Six drugs used: |�| = 6 (the drugs responsible for 
30 % of the expenses of the supply chain – Pareto 
analysis); 
- Three hospitals: |�| = 3 (hospitals belonging to the 
same geographic area); 
- Three medical units for each hospital: |�| = 9 (the 
hospital locations where the chosen drugs are 
mainly used – Pareto analysis). 
 
Moreover, we consider the introduction of a central 
pharmacy with the tasks described in section 3. 
 
6.1 Data collection 
 
6.1.1 Demand data 
 
Drug daily demand for one year for each medical unit 
(9*6=54) has been collected. Mean and standard deviation 
of the Gaussian probability distribution functions are 
reported in Table 3.  
 
6.1.2 Cost and time parameters 
 
The time-driven activity base costing [29] has been 
performed to compute the standard unit cost for each 
logistic activity of the supply chain, obtaining the cost 
parameters considered in the performance function of 
the model. Particular attention has been given to the 
central pharmacy cost parameters’ assessment. Where 
possible, the standard unit cost of the hospital 
pharmacy has been taken into account (see���, ���, 
��� �����in Table 4).  
 
The physical system component of the warehousing cost 
Int J Eng Bus Manag, 2014, 6:21 | doi: 10.5772/589396 www.intechopen.com
(݌ݏ௜) has been fixed at half that of the hospital pharmacy 
due to economies of scale in the central pharmacy 
warehousing system.  
 
The case ݋ݎ௜ǡ௞ is specific because it changes from the AS 
IS to the TO BE logistic organization due to the 
different use level of the hospitals’ information system, 
and, then, the automation of the computations 
involved. In this case, each activity related to the 
ordering task (and the correspondent duration) has 
been accurately addressed to each echelon in each 
logistic system (Table 5). The stockout cost (ݏݐ݋௜ǡ௞) from 
the hospital to the distributor is broken into two parts: 
from hospital to central and from central to distributor. 
A transportation cost (ݐݎ௜ǡ௞) of €40.00 per trip from the 
central pharmacy to a hospital has been assumed, 
leaving aside cost and time savings obtainable with 
routing optimization algorithms.  
 
Time parameters have been collected. Lead times (ܮ ௜ܶǡ௞) 
and transportation times (ܶ ௜ܶǡ௞) of the AS IS model are 
repeated in the TO BE model for the medical unit-hospital 
pharmacy link. 
 








2 6.5 4.8 - - - - 
3 426.0 288.7 73.5 69.5 313.6 315.8 
4 4.0 4.9 - - 5.2 4.4 
5 11.1 9.1 - - 7.3 7.3 








2 6.7 7.3 3.7 8.6 - - 
3 243.0 214.1 384.0 323.4 153.6 137.5 
4 6.0 5.9 6.2 8.0 - - 
5 4.3 5.0 8.4 4.7 6.4 3.8 








2 - - - - 6.0 2.3 
3 79.2 104.6 61.0 64.6 197.2 201.1 
4 - - - - 7.2 3.6 
5 - - - - 5.3 4.3 
6 - - - - 17.9 16.1 
 
Table 3.Mean (ߤ௙ǡ௠) and standard deviation (ߪ௙ǡ௠) of the drugs’ 
demand [packages/day]. Gaussian distribution functions. 
 
In the rest of the TO BE supply chain, the distributors’ 
times are kept. Finally, in order to allow not only “real-
time” data sharing but also “just in time” replenishments, 
the TO BE review period ܴ ௜ܲǡ௙ for all medical units and 
the hospital pharmacy is one day, while for the central 
pharmacy it is three days, equal to the upstream echelon 
(h) of the AS IS model (Table 6). 
 
Point of consumption 
Cost  
Param. 
m h c 
݀݌௜
[€/package] 1 0.50 0.50 
݌ܿ௜
[€/package] 0 0.105 0.073 
݌ݏ௜
[€/package/day] 0.0355 0.0028 0.0014 
݄ݎ௜
[price rate/€/year] 6% 
ݒ௙ǡ௜
׊ ݂ 3 
 
Table 4. Values of the cost parameters at each echelon 
 





Mod. m, h h, c h, d c, d 
݋ݎ௜ǡ௞[€/cod
e]
AS IS 1.70 0 7.45 0 
TO BE 0.08 1.14 0 4.64 
ݏݐ݋௜ǡ௞[€/co
de]
AS IS 150.00 0 2500.00 0 
TO BE 150.00 800.00 0 1700.00
ݐݎ௜ǡ௞[€/trip
]
AS IS 10.00 0 0 0 
TO BE 10.00 40.00 0 0 
ܮ ௜ܶǡ௞
[h]
AS IS 1 0 24 0 
TO BE 1 24 0 24 
ܶ ௜ܶǡ௞
 [h/trip]
AS IS 0.5 0 6 0 
TO BE 0.5 6 0 6 
 
Table 5. Values of the cost and time parameters in the interaction 
between points of consumption for the AS IS and TO BE model 
 
 Point of consumption 
Time 
Param. 
Mod. m h c 
ܴ ௜ܲǡ௙
[d]׊ ݂
AS IS 3 3 0 
TO BE 1 3 1 
ܨܱ ௜ܲǡ௙
[d]׊ ݂
AS IS 0 0 0 
TO BE 1 3 3 
 
Table 6.Values of the time parameters at the points of 
consumption for the AS IS and TO BE model 
 
6.2 Model development 
 
The performances of the two logistic configurations have 
been tested in a simulation environment in order to 
reproduce the variability of medical prescriptions and to 
evaluate the dynamic of ordering, storing and consuming 
drugs along the supply chain, according to the chosen 




Some non-limiting assumptions have been made in order 
to develop the models: 
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- both models are arborescent multi-echelon 
distribution systems, in which the lower echelon 
receives items from only one source belonging to the 
higher echelon (that is, urgencies are managed by 
only looking at the availability of the higher echelon); 
- replenishment lead times (�����) are constant; 
- the time between two physicians’ rounds in a 
medical unit (���) is one day (that is, prescriptions 
change daily); 
- drug demand is stochastically independent among 
days; 
- the maximum time horizon of prescriptions is eight 
days; 




A discrete event simulation model has been developed 
using Arena Rockwell software. Drug packages are the 
entities flowing throughout the system. The time-driven 
occurring events are: 
- medical prescription recording (each ���), which 
defines the needs of drugs at medical units; 
- drug administrations (distributed during the day), 
which determines the consumption of drugs; 
- end of the review period (�����), which calls into 
action inventory management policies to decide the 
time and quantity of orders; 
- order planning(����������), which implies that the 
related picking and order preparation activities take 
place and transportations are activated; 
- stockout, which involves urgent procedures to 
transfer the quantities from the nearest available 
storage location at a high cost (�����������). 
 
A Monte Carlo simulation (MCS) has been used to 
simulate the stochasticity of daily medical prescriptions 
on the basis of collected drugs’ daily demands. Both 
logistic configurations have been subjected to the same 
medical units’ demand. 
 
Inventory management decisions have been implemented 
in VBA (Visual Basic for Application) code. 
 
At the end of each simulation, the time series of 
prescriptions, stocks, orders and stockouts are provided, 
together with the value of each cost item.  
 
The simulation length has been one year. A number of 
replications have been provided to compensate for the 
effects of extractions over the time of the MCS, and thus 
accurately reproduce the drug demand distributions.  
 
7. Design and analysis of experiments 
 
The cost performances of the two logistic systems have 
been investigated in three different experiments: 
1. under the case study; 
2. under the variation of the fixed order period of the 
central pharmacy; 
3. in the case of pure GPO. 
 
No quantity discount ��(due both to the GPO’s 
bargaining power and the distribution task transfer to the 
central pharmacy) has been implemented in the basic 
simulation model, because it is strictly dependent on the 
GPO dimension, drug type and volume, suppliers’ 
competition, location and hospitals’ accessibility. This 
sure saving has to be added to the one found in the 
simulation comparisons, and it affects not only the 
purchasing cost but also the warehousing cost, because of 
the holding cost (���) variation.  
 
For the same reason, no experiment has been carried out 
assessing the convenience of the introduction of a 3PL. 
 
The cost comparison between the systems is carried out 
by means of the synthetic performance indicator (mean 




������   (12) 
 
Moreover, the distinction between purchasing costs 
savings (%������)and logistic cost savings (%������)is 
made. 
 





Figure 2. Summary of the experimental results. Mean total cost 
saving (%������) and logistic costs savings (dotted line,%������) 
in the simulated scenarios (discussed later). 
 
7.1 The case study experiment 
 
In this first experiment, the economic saving of the 
centralization of purchasing, warehousing and decisions 
is evaluated by the case study contest. 
 
Generally, a three-day review period inventory policy in 
the absence of communication in a two-echelonnetwork 
(AS IS) is opposed to a one-day review period with 
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prescription data sharing in a three-echelon supply chain, 
where the central pharmacy rules the system on the basis 
of requirements, andit is in charge of daily 
transportations and ordering to cover requirements for 
three days forward.  
 
The simulation length, along with the number of 
repetitions, ensures that the real demand variability over 
time has been accurately reproduced during the 
simulation runs. The standard errorof%�_����, with a 
confidence level of 95%, is 0.0044 [30]. 
 
The experiment shows that the TO BE logistic system is 
much more convenient than the AS IS one: while assuring 
the same service level to patients (proportional to ����), 
the mean total cost saving (%�_����) of the supply chain 
is4.53 %.Moreover, both the purchasing and logistic costs 
can be reduced with the TO BE model:  
- %�_���� = 1.02%; 
- %�_���� = 28.21%. 
It is not surprising that there is a saving in the purchasing 
costs �� even if the consumed quantities are the same in 
both models. Indeed, in the AS IS model, the materials 
are purchased to restore the par level (S), but part of them 
is not used because it is notprescribed to patients. By 
contrast, in the TO BE model,only what is really needed is 
bought (given the adoption of the MRP method). 
 
The logistic cost savings are due to a number of reasons, 
so it is worth examining the cost distribution among the 
cost items in the AS IS and the TO BE configurations 
(Table 7). 
 
 Logistic cost items 
��� �� ��� �� �� 
AS IS cost composit. 21% 5% 14% 2% 58%
%����(TO BE on AS IS 
models) 
-69% 54% 64% -586% 80%
 
Table 7. AS IS expenditure distribution for the logistic costs 
items and percentage of savings thanks to the TO BE model 
adoption 
 
The handling cost ���is a significant component of the AS 
IS logistic costs (21%) due to the labour-intensive tasks. It 
increases in the TO BE model because the distribution 
from a new echelon (the central pharmacy) has to be 
managed. For the same reason, the transportation costs 
��rise. On the other hand, the ordering cost ��records a 
decrease due to the automation introduced by the 
information system. Theevident re-ordination logic and 
the shorter �����of the TO BE model are the reasons for 
the reduction instockout costs ���and warehousing costs 
��, whichaccount for more than half of the total logistic 
costs of the AS IS supply chain.  
7.2 Variation of the central pharmacy fixed order period  
 
This second experiment deals with the possibility of 
balancing the increase in transportation costs from the 
central pharmacy to hospitals with reducing the 
frequency of orders from distributors (low FOP) and, 
thus, the corresponding costs. In return, obviously, the 
central pharmacy warehousing costs will increase. The 
opposite strategy is to boost the central pharmacy FOP to 
drastically reduce the �� while ��isincreased. 
 
Table 8 shows the experimental levels of ������ and the 
savings results. 
 
Factor Level %�_���� %�_���� %�_���� %�_������ = 3% 
������ 
[day] 
1 4.06% 20.25% 1.66%	 6.65%
3 (case 
study)
4.53% 28.21% 1.02%	 7.14%
5 4.23% 27.18% 0.83%	 6.77%
 
Table 8.TO BE mean cost savings depending on ������ variations 
 
The results clearly show that ������has to be set 
according to the supply chain cost structure in order to 
achieve the maximum benefit.In any case, the sharing of 
patient information always assuresa total cost saving, and 
there is a procurement reduction the lower ������	is, 
because frequent orders better follow the demand. 
 
Moreover, if the central pharmacy is able to negotiate, for 
example, a 3% quantity discount (��) on the purchasing, 
the total savings are greater (last column of Table 8). 
 
7.3 Pure GPO 
 
The last experiment has been carried out to evaluate the 
economic convenience of centralizing bids and orders 
while keeping the reception and storage of materials at 
the individual hospitals. This last configuration is a pure 
GPO in which the central pharmacy has the role of 
demand aggregator provided by a virtual warehouse. 
Obviously, the ordering cost parameter (�����) at each 
echelon has been recalculated accounting for the new task 
distributions among supply chain actors.The FOP setting 
and the experimental’ results are reported in Table 9. 
 
This logistic configuration shows higher savings than the 
other tested scenario. The savings in purchasing costs due 
to shorter ������matchthe lower warehousing costs 
because of the elimination of the physical centralization 
of stocks. The ordering costs, which have a short weight 
on the total AS IS costs, rise due to the duplication of 
some tasks at the hospital pharmacy echelon.  
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Because the economic crisis and competition have led 
hospitals to faceincreasing financial pressures, healthcare 
supply chain integration has become a topic of interest for 
researchers and practitioners. Three main logistic 
strategies have emerged: GPO, centralization of inventory 
and outsourcing to a 3PL.The main demonstrated 
advantages have been price-quantity discount, savings in 
warehousing costs, focus on core activities and 
prevention of corruption, even if some other budget items 
have been identified as checkpoints, such as coordination 
and distribution costs. 
 
As a worldwide trend, medical supply centralization has 
been implemented in many contexts, both growing out of 
bottom-up initiatives and imposed by governments, as in 
the case of the compulsory administration of healthcare in 
some Italian regions. 
 
On the other hand, the pervasiveness of information and 
communication technologies – reflected in the 
introduction of electronic medical records, RFID for 
patients and medical devices, and hospital enterprise 
resource planning systems [31] – has not been fully 
exploited to improve operations management.  
 
This research proposes an integration of both 
centralization and information technology trends in 
healthcare, to provide better and cheaper care to patients.  
 
In particular, the economic convenience of cooperation in the 
pharmaceutical supply chain from the patient’s bed to the 
drug distributor by means of sharing patients’ prescriptions 
has been assessed. The logistic network under investigation 
(TO BE model) integrates: a central pharmacy negotiating 
with suppliers, collecting hospital orders, storing and 
distributing materials;a number of hospitals feeding their 
medical units with materials; and a number of medical units 
taking care of their patients. 
 
The quantitative study has been carried out comparing 
the cost performances of this model with a non-
cooperative supply chain, where hospitals manage their 
stocks individually (AS IS model).  
 
Monte Carlo simulation has been used to reproduce the 
variability of prescription requirements over time in a 
discrete event simulation environment. Costs and time 
parameters to perform the comparison come from a case 
study. 
 
The convenience of a centralization of inventory or of the 
introduction of a pure GPO has been evaluated. The results 
are impressive, showing that there is always a cost saving in 
adopting the cooperative model, including in situations 
without price-quantity discounts, when varying the period 
of central pharmacy order aggregation (FOP) or when 
completely avoiding the physical centralization of stocks. 
 
Further studies should explore the effect of stochastic 
supplier leadtimes on the cost savings. Finally,logistic 
resources’ capacities and their load conditions could be 
analysed to optimize the frequency and scheduling of 




[1] OECD (2013) Health at a Glance 2013: OECD 
Indicators. OECD Publishing. 
[2] Tordoff JM, Norris PT, Reith DM (2008) “Price 
management” and its impact on hospital 
pharmaceutical expenditure and the availability of 
medicines in New Zealand hospitals. Value in 
Health: The Journal of the International Society for 
Pharmacoeconomics and Outcomes Research 11(7): 
1214–1226.  
[3] Landry S, Beaulieu M (2013) The challenges of 
hospital supply chain management, from central 
stores to nursing units.In Handbook of Healthcare 
Operations Management: Methods and Applications. 
International Series in Operations Research & 
Management Science 184.  
[4] Gebicki M, Mooney E, Chen SJ, Mazur LM (2013) 
Evaluation of hospital medication inventory 
policies.Health Care Management Science. 
[5] Iannone R, Lambiase A, Miranda S, Riemma S, Sarno 
D (2013) Modelling hospital materials management 
processes. International Journal of Engineering 
Business Management5 (15): 1- 12. 
[6] Vila-Parrish AR, Simmons Ivy J (2013) Managing 
supply critical to patient care: An introduction to 
hospital inventory management for pharmaceutical.In 
Handbook of Healthcare Operations Management: 
Methods and Applications. International Series in 
Operations Research & Management Science 184.  
[7] Essoussi IE, Ladet P (2009) Towards resource pooling 
in cooperative health care networks: Case of medical 
supply centralization. In International Conference on 
Computers Industrial Engineering, 2009. CIE 2009: 
600–605. 
[8] Rego N, Claro J, de Sousa JP (2013) A hybrid 
approach for integrated healthcare cooperative 
purchasing and supply chain configuration. Health 
Care Management Science [Epub ahead of print]. 
Int J Eng Bus Manag, 2014, 6:21 | doi: 10.5772/5893910 www.intechopen.com
[9] Nenni ME, Giustiniano L (2013) Increasing 
integration across the supply chain through an 
approach to match performance and risk. American 
Journal of Applied Sciences 10(2): 1009–1017.  
[10] Eppen GD (1979) Effects of centralization on 
expected costs in a multi-location newsboy problem. 
Management Science 25(5): 498–501. 
[11] Chen M-S, Lin C-T (1989) Effects of centralization on 
expected costs in a multi-location newsboy problem. 
The Journal of the Operational Research Society 
40(6): 597–602. 
[12] Baboli A, Fondrevelle J, Tavakkoli-Moghaddam R, 
Mehrabi A (2011) A replenishment policy based on joint 
optimization in a downstream pharmaceutical supply 
chain: Centralized vs. decentralized replenishment. The 
International Journal of Advanced Manufacturing 
Technology 57 (1–4): 367–78.  
[13] Iannone R, Miranda S, Riemma S, Sarno D (2010) A 
model for vendor selection and dynamic evaluation. 
IFIP Advances in Information and Communication 
Technology 338: 283-290.  
[14] Nicholson L, Vakharia AJ, Erenguc SS (2004) 
Outsourcing inventory management decisions in 
healthcare: Models and application. European 
Journal of Operational Research 154: 271–290. 
[15] Danese P (2006) The extended VMI for coordinating 
the whole supply network. Journal of Manufacturing 
Technology Management 17(7): 888–907. 
[16] Waller M, Johnson M, Davis T (1999) Vendor-
managed inventory in the retail supply chain. 
Journal of Business Logistic 20 (1): 183-203.  
[17] Huang GQ, Lau SK, Mak KL (2003) The impacts of 
sharing production information on supply chain 
dynamics: A review of the literature. International 
Journal of Production Research 41(7): 1483 – 1517. 
[18] Dobson G, Tilson D, Tilson V, Haas CE (2014) 
Quantitative case study: Use of pharmacy patient 
information systems to improve operational 
efficiency. In 2014 47th Hawaii International 
Conference on System Sciences (HICSS): 4220–28. 
[19] Mehrabi A, Baboli A, Campagne JP (2009) A method 
for the determination of safety stock levels in order to 
study the effect of replenishment leadtime information 
sharing. In International Conference on Computers 
Industrial Engineering, 2009. CIE 2009: 1641–46. 
[20] Fera M, Iannone R, Mancini V, Schiraldi MM, Scotti P 
(2013) Economic evaluation of RFID technology in 
the production environment. International Journal of 








[21] Schneller ES, Smeltzer LR, Burns LR (2006) Strategic 
Management of the Health Care Supply Chain. 1st 
edition. Jossey-Bass, San Francisco. 
[22] Iannone R, Lambiase A, Miranda S, Riemma S, Sarno 
D (2014) Cost savings in hospital materials 
management: Look-back versus look-ahead 
inventory policies. International Journal of Services 
and Operations Management. In press. 
[23] Iannone R, Miranda S, Riemma S, Sarno D (2011) 
Proposal of a conceptual framework to optimise drug 
management in healthcare systems. Proceedings of 
the IADIS International Conference e-Health 2011, 
Part of the IADIS Multi Conference on Computer 
Science and Information Systems 2011, MCCSIS 2011: 
215–220. 
[24] Guida R, Iannone R, Miranda S, Riemma S, Sarno D 
(2012) From patients’ needs to hospital pharmacy 
management - an holistic approach to the process 
modelling. Proceedings of the International 
Workshop on Innovative Simulation for Healthcare 
2012, Part of the International Multidisciplinary 
Modeling and Simulation Multiconference 2012, I3M 
2012: 56-62. 
[25] Bregni A, D'Avino M, De Simone V, Schiraldi MM 
(2013) Formulas of revised MRP.International 
Journal of Engineering Business Management 5: 1–8. 
[26] D’Avino M, Bregni A, Schiraldi MM (2013) A revised 
and improved version of the MRP algorithm: Rev 
MRP, 328: 276-280. 
[27] Chase R, Aquilano N, Jacobs F (1998) Production and 
Operations Management: Manufacturing and 
Services. Irwin McGraw-Hill. 
[28] Dellaert N, van de Poel E (1996) Global inventory 
control in an academic hospital. International Journal 
of Production Economics 46: 277–284. 
[29] Kaplan RS, Porter ME (2011) How to solve the cost 
crisis in health care. Harvard Business Review 7(27): 
47–64. 
[30] Chung CA (2004) Simulation Modeling Handbook: A 
Practical Approach. CRC Press, Boca Raton. 
[31] Fruggiero F, Iannone R, Riemma S (2011) The care for 
planning and control in a framework for hospital 
management. Proceedings of the IADIS International 
Conference e-Health 2011, Part of the IADIS Multi 
Conference on Computer Science and Information 





Raffaele Iannone, Alfredo Lambiase, Salvatore Miranda, Stefano Riemma and Debora Sarno: 
Pulling Drugs Along the Supply Chain: Centralization of Hospitals’ Inventory
11www.intechopen.com
